硝苯地平治疗心绞痛：硝苯地平与缓释硝苯地平单独及联合阿替洛尔的双盲比较。
Treatment of angina pectoris with nifedipine: a double blind comparison of nifedipine and slow-release nifedipine alone and in combination with atenolol.
作者信息
Crake T, Quyyumi A A, Wright C, Mockus L, Fox K M
机构信息
National Heart Hospital, London.
出版信息
Br Heart J. 1987 Dec;58(6):617-20. doi: 10.1136/hrt.58.6.617.
Abstract
The relative efficacy of nifedipine and slow-release nifedipine (Adalat Retard) in the treatment of stable exertional angina pectoris was evaluated in a double blind randomised crossover study in eight patients on no concomitant antianginal treatment and in 10 patients who were additionally on atenolol. Patients were assessed by angina diaries and exercise testing. Slow-release nifedipine was as effective as nifedipine in the treatment of these patients, both alone and in combination with atenolol.
摘要
在一项双盲随机交叉研究中，对8例未接受其他抗心绞痛治疗的患者以及10例同时服用阿替洛尔的患者，评估了硝苯地平和缓释硝苯地平（拜新同缓释片）治疗稳定型劳力性心绞痛的相对疗效。通过心绞痛日记和运动试验对患者进行评估。缓释硝苯地平在单独使用以及与阿替洛尔联合使用时，治疗这些患者的效果与硝苯地平相当。
相似文献
1
Treatment of angina pectoris with nifedipine: a double blind comparison of nifedipine and slow-release nifedipine alone and in combination with atenolol.硝苯地平治疗心绞痛：硝苯地平与缓释硝苯地平单独及联合阿替洛尔的双盲比较。
Br Heart J. 1987 Dec;58(6):617-20. doi: 10.1136/hrt.58.6.617.
2
Medical treatment of patients with severe exertional and rest angina: double blind comparison of beta blocker, calcium antagonist, and nitrate.重度劳力性和静息性心绞痛患者的药物治疗：β受体阻滞剂、钙拮抗剂和硝酸盐的双盲比较
Br Heart J. 1987 Jun;57(6):505-11. doi: 10.1136/hrt.57.6.505.
3
Comparison of the efficacy of atenolol and its combination with slow-release nifedipine in chronic stable angina.
Cardiovasc Drugs Ther. 1993 Dec;7(6):909-13. doi: 10.1007/BF00877726.
4
Slow release nifedipine plus atenolol in chronic stable angina pectoris.缓释硝苯地平联合阿替洛尔治疗慢性稳定型心绞痛
Br J Clin Pharmacol. 1989 Nov;28(5):509-16. doi: 10.1111/j.1365-2125.1989.tb03536.x.
5
Atenolol with and without nifedipine in the treatment of angina pectoris. Preliminary report.阿替洛尔联合或不联合硝苯地平治疗心绞痛。初步报告。
Drugs. 1988;35 Suppl 4:51-5. doi: 10.2165/00003495-198800354-00012.
6
7
Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina.硝苯地平、单硝酸异山梨酯与阿替洛尔联合应用治疗稳定型心绞痛的疗效
Lancet. 1991 Oct 26;338(8774):1036-9. doi: 10.1016/0140-6736(91)91900-f.
8
The combination of slow-release nifedipine and atenolol for stable angina.
Cardiovasc Drugs Ther. 1990 Aug;4 Suppl 5:899-904. doi: 10.1007/BF02018289.
9
Comparison of nifedipine gastrointestinal therapeutic system and atenolol on antianginal efficacies and exercise hemodynamic responses in stable angina pectoris.
Am J Cardiol. 1994 Jan 1;73(1):23-8. doi: 10.1016/0002-9149(94)90721-8.
引用本文的文献
1
2
Slow release nifedipine plus atenolol in chronic stable angina pectoris.缓释硝苯地平联合阿替洛尔治疗慢性稳定型心绞痛
Br J Clin Pharmacol. 1989 Nov;28(5):509-16. doi: 10.1111/j.1365-2125.1989.tb03536.x.
3
Development of tolerance to nifedipine in patients with stable angina pectoris.稳定型心绞痛患者对硝苯地平耐受性的发展
Br J Clin Pharmacol. 1990 Mar;29(3):339-46. doi: 10.1111/j.1365-2125.1990.tb03645.x.
4
The combination of slow-release nifedipine and atenolol for stable angina.
Cardiovasc Drugs Ther. 1990 Aug;4 Suppl 5:899-904. doi: 10.1007/BF02018289.
5
Evaluation of the antianginal effect of nifedipine: influence of formulation dependent pharmacokinetics.
Eur J Clin Pharmacol. 1991;40(5):501-6. doi: 10.1007/BF00315230.
6
Effects of atenolol, slow-release nifedipine, and their combination on respiratory gas exchange and exercise tolerance in stable effort angina.
Klin Wochenschr. 1991 Sep 16;69(14):645-51. doi: 10.1007/BF01649425.
7
Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.阿替洛尔：对其药理特性及在心血管疾病治疗应用的重新评估
Drugs. 1991 Sep;42(3):468-510. doi: 10.2165/00003495-199142030-00007.
本文引用的文献
1
Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination.抗心绞痛治疗的客观评估：普萘洛尔、硝苯地平及其联合用药的双盲比较。
Br Med J. 1980 Jul 19;281(6234):184-7. doi: 10.1136/bmj.281.6234.184.
2
Bioavailability of nifedipine: a comparison between two preparations.硝苯地平的生物利用度：两种制剂的比较。
Biopharm Drug Dispos. 1984 Apr-Jun;5(2):109-15. doi: 10.1002/bdd.2510050204.
3
Treatment of angina pectoris with nifedipine: importance of dose titration.硝苯地平治疗心绞痛：剂量滴定的重要性。
Br Med J (Clin Res Ed). 1983 May 7;286(6376):1467-70. doi: 10.1136/bmj.286.6376.1467.
4
Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects.钙通道阻滞剂在心血管疾病治疗中的应用。第一部分：基础与临床电生理效应
Ann Intern Med. 1980 Dec;93(6):875-85. doi: 10.7326/0003-4819-93-6-875.
5
A double blind placebo controlled comparison of verapamil, atenolol, and their combination in patients with chronic stable angina pectoris.维拉帕米、阿替洛尔及其联合用药治疗慢性稳定型心绞痛患者的双盲安慰剂对照比较
Br Heart J. 1987 Apr;57(4):336-43. doi: 10.1136/hrt.57.4.336.
6
Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function.硝苯地平和阿替洛尔治疗心绞痛：疗效及对心功能的影响。
Br Heart J. 1986 Mar;55(3):240-5. doi: 10.1136/hrt.55.3.240.
7
Evaluation of the efficacy of slow-release nifedipine in systemic hypertension by ambulatory intraarterial blood pressure monitoring.通过动态动脉内血压监测评估缓释硝苯地平治疗系统性高血压的疗效。
J Cardiovasc Pharmacol. 1985 Jan-Feb;7(1):145-51. doi: 10.1097/00005344-198501000-00024.
8
Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle.钙在心肌、心脏起搏器和血管平滑肌中的特殊药理学。
Annu Rev Pharmacol Toxicol. 1977;17:149-66. doi: 10.1146/annurev.pa.17.040177.001053.
Zotero 插件